Skip to main content
. 2008 Dec;4(6):1211–1224. doi: 10.2147/ndt.s4716

Figure 1.

Figure 1

Trial design used in a pregabalin randomized flexible-dose (150–600 mg/day) versus fixed-dose (600 mg/day) double-blind adjunctive-therapy trial in patients with refractory partial-onset seizures, with or without secondary generalization. Adapted from Elger et al 2005.